InsiderTrades.com logo
This company will win the AI race
From Porter & Company   |   Ad
Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.
You must read this new presentation from Porter Stansberry.

SNPX Insider Trading

Insider Ownership Percentage: 2.73%
Insider Buying (Last 12 Months): $0.00
Insider Selling (Last 12 Months): $0.00

Synaptogenix Insider Trading History Chart

This chart shows the insider buying and selling history at Synaptogenix by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

Synaptogenix Share Price & Price History

Current Price: $2.60
Price Change: ▲ Price Increase of +0.04 (1.56%)
As of 11/22/2024 01:00 AM ET

This chart shows the closing price history over time for SNPX up to the past year.

Skip Chart and Table DataPrice Data in Insider Trading History Table
Days: 30 | 90 | 365
A “Thank You Gift” From Pres. Trump - Genius
From Colonial Metals   |   Ad
Trump quietly left open an "off the books" wealth-protection loophole hidden in the 6,871 pages of the IRS Tax Code… And since then… "In the know" patriots have quietly used this same "Trump revenge loophole" to shield their life savings from Bidenomics…
Get Your Free Gold Guide

Synaptogenix Insider Trading History

Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
12/16/2022Daniel L. AlkonInsiderSell787$29.25$23,019.751,421View SEC Filing Icon  
12/16/2022William S SingerDirectorSell1,080$29.25$31,590.001,320View SEC Filing Icon  
See Full Table
Trump’s Sending THIS Crypto Higher on Purpose
From Crypto 101 Media   |   Ad
Discover the coin set to explode before 2025! Trump could trigger THIS crypto coin…
YES, I WANT THE #1 CRYPTO NOW

SEC Filings (Institutional Ownership Changes) for Synaptogenix (NASDAQ:SNPX)

10.34% of Synaptogenix stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

This chart shows the instiutional buying and selling at SNPX by year and by quarter.

Skip Institutional Buying and Selling Chart and Table DataRead Chart Data in Institutional Trading History Table

Synaptogenix Institutional Trading History

Reporting DateHedge FundShares HeldMarket Value% of PortfolioQuarterly Change in SharesOwnership in CompanyDetails
2/3/2023Cannell & Co.30,000$35K0.0%-60.6%0.413%Search for SEC Filing on Google Icon
1/11/2023Platform Technology Partners25,138$29K0.0%+56.8%0.346%Search for SEC Filing on Google Icon
8/12/2022Ikarian Capital LLC121,191$0.61M0.1%-20.9%1.772%Search for SEC Filing on Google Icon
5/3/2022Platform Technology Partners16,032$0.12M0.1%-25.0%0.235%Search for SEC Filing on Google Icon
2/14/2022Diametric Capital LP30,521$0.26M0.2%-17.2%0.457%Search for SEC Filing on Google Icon
2/7/2022Orion Capital Management LLC4,000$34K0.0%N/A0.060%Search for SEC Filing on Google Icon
2/1/2022Platform Technology Partners21,375$0.18M0.1%-34.2%0.320%Search for SEC Filing on Google Icon
9/17/2021Virtu Financial LLC14,259$0.14M0.0%N/A0.232%Search for SEC Filing on Google Icon
8/18/2021Ikarian Capital LLC300,000$2.96M0.2%N/A4.968%Search for SEC Filing on Google Icon
8/17/2021Worth Venture Partners LLC73,909$0.64M0.2%N/A1.224%Search for SEC Filing on Google Icon
8/17/2021Boothbay Fund Management LLC34,079$0.34M0.0%N/A0.564%Search for SEC Filing on Google Icon
8/16/2021Diametric Capital LP21,901$0.22M0.2%N/A0.363%Search for SEC Filing on Google Icon
8/12/2021AIGH Capital Management LLC316,945$2.83M0.5%N/A5.248%Search for SEC Filing on Google Icon
8/10/2021CM Management LLC10,000$99K0.1%N/A0.166%Search for SEC Filing on Google Icon
8/5/2021Platform Technology Partners32,500$0.32M0.1%N/A0.538%Search for SEC Filing on Google Icon
Data available starting January 2016

See Full Table
Synaptogenix logo
Synaptogenix, Inc. operates as a biopharmaceutical company with product candidates in pre-clinical and clinical development. The company focuses on developing a product platform based upon a drug candidate called Bryostatin-1 for the treatment of Alzheimer's disease. It also evaluates therapeutic applications of bryostatin for other neurodegenerative or cognitive diseases and dysfunctions, such as fragile X syndrome, multiple sclerosis, and Niemann-pick type C disease. The company was incorporated in 2012 and is headquartered in New York, New York.
Read More on Synaptogenix

Today's Range

Now: $2.60
Low: $2.35
High: $2.60

50 Day Range

MA: $3.00
Low: $2.40
High: $3.60

52 Week Range

Now: $2.60
Low: $2.32
High: $8.78

Volume

4,605 shs

Average Volume

14,421 shs

Market Capitalization

$3.53 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.19

Who are the company insiders with the largest holdings of Synaptogenix?

Synaptogenix's top insider investors include:
  1. Daniel L Alkon (Insider)
  2. William S Singer (Director)
Learn More about top insider investors at Synaptogenix.
This company will win the AI race
From Porter & Company   |   Ad
Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.
You must read this new presentation from Porter Stansberry.